PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1425007
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1425007
Fluoroscopy Market size was valued at USD 4,974.2 Million in 2022, expanding at a CAGR of 8.2% from 2023 to 2030.
Fluoroscopy serves as a medical imaging technique that provides real-time X-ray images displayed continuously on a monitor. During fluoroscopy procedures, a controlled X-ray pulse traverses the body, and the resulting imagery is transmitted to a camera, allowing for intricate analysis of the movement of body parts, instruments, or contrast agents within the body. This imaging modality is instrumental in the diagnosis of medical conditions and guiding various treatment interventions. While certain fluoroscopy procedures can be performed as outpatient examinations with the patient awake, others are typically carried out as inpatient procedures within a hospital setting, often requiring sedation or general anesthesia. For instance, cardiac catheterization assesses the heart and its coronary arteries during surgery, and it is one of the fluoroscopy procedures performed under general anesthesia.
Fluoroscopy Market- Market Dynamics
Rising prevalence of both communicable and chronic diseases, alongside an increasing awareness among the public regarding hospital-acquired infections is expected to propel the market demand
The global fluoroscopy equipment market is on the rise due to an increase in the prevalence of conditions requiring pain management, trauma, gastrointestinal disorders, and urological disorders. It is also driven by the growing aging population and the need for clear visualization of specific anatomical regions. Additionally, the surge in fluoroscopy equipment adoption by patients, heightened awareness among healthcare professionals regarding its utilization, and the rising incidence of cardiovascular diseases contribute to market growth. However, challenges include complications and side effects related to contrast agents and the substantial cost associated with fluoroscopy equipment.
The COVID-19 pandemic, declared a global public health emergency by the World Health Organization (WHO) on January 30, 2021, has had far-reaching consequences. With lockdowns, government regulations, and the ongoing spread of the virus, neurology hospitals and clinics have experienced significant financial impacts. Many healthcare facilities have seen reduced patient visits, delays in diagnostic procedures that involve fluoroscopy equipment, and cancellations or postponements of non-essential or non-urgent examinations. Moreover, the limited availability of healthcare personnel worldwide has also adversely affected the fluoroscopy equipment market.
Fluoroscopy Market- Key Insights
As per the analysis shared by our research analyst, the global Fluoroscopy Market is estimated to grow annually at a CAGR of around 8.2% over the forecast period (2023-2030)
The Fluoroscopy Market is projected to grow at a significant rate driven by rising prevalence of both communicable and chronic diseases, alongside an increasing awareness among the public regarding hospital-acquired infections
Based on product type, the fluoroscopic devices segment was predicted to show maximum market share in the year 2022
Based on Application, Cardiovascular was the leading Segment in 2022
On the basis of region, North America was the leading revenue generator in 2022
The Global Fluoroscopy Market is segmented on the basis of Product Type, By Application, and Region.
Based on product type, the market is divided into two segments: Fluoroscopy devices and C-arm. In the realm of medical devices, the fluoroscopic devices segment stands as the primary driver of revenue and is poised for substantial growth throughout the forecast period. This growth is attributed to several key factors, including the escalating adoption of fluoroscopic devices, a rising incidence of cardiovascular diseases, the demand for effective pain management solutions, increased investments in research and development for advancing fluoroscopic equipment, a growing elderly population, the introduction of cutting-edge technological products, and an upsurge in the launch of new and advanced fluoroscopic devices.
The market is categorized by Application into six segments: Cardiovascular, Pain Management and Trauma, Neurology, Gastrointestinal, Urology, General Surgery, Other Applications. Regarding its application, the cardiovascular diseases segment is expected to be a prominent contributor to the fluoroscopy equipment market during the forecast period. This projection is underpinned by factors such as the increasing prevalence of stroke and heart-related diseases, government initiatives aimed at modernizing healthcare infrastructure, ongoing technological advancements in diagnostic equipment, and the continued approval of fluoroscopic equipment for superior diagnosis of cardiovascular diseases compared to conventional methods.
Fluoroscopy Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the largest market share over the forecast period because of the established healthcare system, the rising prevalence of chronic illnesses, and the active involvement of key industry participants in the research and introduction of new products.
Companies operating in the fluoroscopy market are actively engaged in advancing medical imaging technology to provide innovative solutions for healthcare professionals. These companies invest heavily in research and development to enhance the quality and precision of fluoroscopy equipment while reducing radiation exposure to patients and healthcare providers. They aim to address the increasing demand for real-time imaging in various medical specialties, such as cardiology, orthopedics, and gastroenterology. Furthermore, strategic collaborations with healthcare institutions and regulatory authorities play a pivotal role in obtaining approvals and expanding market presence. Companies also focus on expanding their product portfolios to cater to a wider range of clinical applications and healthcare settings, including the introduction of portable and mobile fluoroscopy systems. Additionally, efforts are made to ensure compliance with stringent quality standards and regulations, ensuring the safety and efficacy of fluoroscopy devices in clinical practice.
In August 2022, Xoran Technologies obtained clearance from the USFDA (510(k)) for TRON, a mobile full-body fluoroscopy and computed tomography (CT) X-ray system. Tailored for constrained spaces such as operating rooms, surgery centers, and critical care units, TRON is an ideal solution providing secure, ultra-high-resolution, low-dose imaging.
In July 2022, Fujifilm Healthcare Americas Corporation, a provider of diagnostic and enterprise imaging solutions, introduced FDR Cross, an innovative hybrid c-arm and portable x-ray solution designed for use in hospitals and ambulatory surgery centers (ASC). This groundbreaking dual-function c-arm is the first of its kind to offer portable fluoroscopic and radiographic imaging capabilities on a single platform, eliminating the necessity for additional imaging equipment during vital image-guided procedures.